“The term ‘biotransformation’ may be unfamiliar to some in the industry, but it refers to fermentation and other natural processing methods that involve transforming compounds within a living system,” said General Manager Marc Philouze. “It describes exactly what we do. We use living microorganisms to transform compounds into usable nutritional actives.”

The business unit draws on its focused research and applications capabilities, rigorous quality and regulatory compliance, and extensive clinical validation procedures to develop effective solutions for its key markets: Wellness & Immune Health, Digestion & Gut Health, Mobility & Joint Health, Reproduction & Women’s Health, and Mood & Cognitive Health.

“In the past, we have focused solely on building awareness for our renowned ingredients, such as Quatrefolic® and Lynside® nutritional yeasts,” said Global Marketing Director Philippe Caillat. “At the same time, we have been building our expertise and market leadership for our key market segments, so we are proud to bring those to the forefront of our brand strategy.”

Within its market segments, Gnosis by Lesaffre has developed a portfolio of solutions that improve health and wellbeing throughout the entire body:

Wellness & Immune Health: Immunity, Daily Nutrition, Cardiovascular Health, Beauty, and General Wellbeing

Digestion & Gut Health: Microbiome Balance, Digestive Comfort, and Liver Health Support

Mobility & Joint Health: Bone Health, Joint Health, Muscle Health, and Sports Nutrition

Reproduction & Women’s Health: Vaginal Care, Urinary Health, Fertility, Pregnancy, and Menopause

Mood & Cognitive Health: Mood Health, Cognition, and Stress & Anxiety

The Lesaffre Group entered the human health market in 2007 with the establishment of Lesaffre Human Care, which quickly became a world expert in fermentation dedicated to the human nutrition and health market. Over the following decade, the Lesaffre Group integrated several leaders in human health, including Gnosis Advanced Biotech, Omniabios, and invested in Envera and Intralytix.

“We’ve brought together leaders in human health and nutrition from around the world to form the now fully integrated Gnosis by Lesaffre,” added Philouze. “We’re committed to always exploring the potential of biotransformation, which we believe is limitless. It’s truly an untapped, transformative resource that will help us develop natural, sustainable, and efficacious solutions for our partners.”

Gnosis by Lesaffre is presenting a webinar entitled “Exploring Life to Improve Living” on Oct. 28 at 6 pm CET/12 pm EST. Webinar participants will learn how microbial biotransformation can help brands develop products that help their customers, and ultimately consumers, thrive. 

Register for the Oct. 28 webinar.

Learn more about Gnosis by Lesaffre.

About Gnosis by Lesaffre

Gnosis by Lesaffre harnesses the power of microorganisms and biotransformation processes like fermentation to cultivate nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and wellbeing. The team draws on its focused research and applications capabilities to collaborate with nutraceutical and pharmaceutical brands to develop game-changing products for their customers.

About Lesaffre

A key global player in fermentation for more than a century, Lesaffre, with a 2,2 billion euro turnover, and established on all continents, counts 10,700 employees and more than 70 nationalities. On the strength of this experience and diversity, we work with customers, partners and researchers to find ever more relevant answers to the needs of food, health, naturalness and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms.

To nourish 10 billion people, in a healthy way, in 2050 by making the most of our planet’s resources is a major and unprecedented issue. We believe that fermentation is one of the most promising answers to this challenge.